Post by Johnson & Johnson

Over 1 million people are diagnosed with bladder cancer every year. However, treatment options and outcomes remain challenging—highlighting the ongoing need for research in this area. Guided by his experience as a urologist, Christopher is now one of our scientists leading efforts to develop novel ways to deliver therapies and ensure these innovations are accessible to all patients.​ Read about how he and his team approach bladder cancer innovation.